ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autoimmune Disorder Drug Delivery Device Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-0K8018
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Autoimmune Disorder Drug Delivery Device Market Insights Forecast to 2028
BUY CHAPTERS

Global Autoimmune Disorder Drug Delivery Device Market Research Report 2025

Code: QYRE-Auto-0K8018
Report
July 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Amgen Inc
F Hoffmann La Roche Ltd
Novartis
GlaxoSmithKline PLC
Biogen
Merck KGaA
Bayer
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd
Eli Lily And Company
Sanofi
Takeda Pharmaceutical Company Limited

Autoimmune Disorder Drug Delivery Device Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Autoimmune Disorder Drug Delivery Device Market

Autoimmune Disorder Drug Delivery Device Market

The global market for Autoimmune Disorder Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The exponential rise in the adoption of self-injection devices for the treatment of autoimmune disorders has created a buzz among companies to invest in the development of novel autoimmune disorder drug delivery devices. Due to the leading market products and intense market penetration, Amgen Inc. has been a pioneer in this field and has been a significant competitor in this market.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Autoimmune Disorder Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disorder Drug Delivery Device.
The Autoimmune Disorder Drug Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autoimmune Disorder Drug Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disorder Drug Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Autoimmune Disorder Drug Delivery Device Market Report

Report Metric Details
Report Name Autoimmune Disorder Drug Delivery Device Market
CAGR 5%
Segment by Type
Segment by Application
  • In-house Manufacturing
  • Outsourced Manufacturing
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Biogen Inc., Merck KGaA, Bayer AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Eli Lily and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Autoimmune Disorder Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Autoimmune Disorder Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Autoimmune Disorder Drug Delivery Device Market report?

Ans: The main players in the Autoimmune Disorder Drug Delivery Device Market are AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Biogen Inc., Merck KGaA, Bayer AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Eli Lily and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited

What are the Application segmentation covered in the Autoimmune Disorder Drug Delivery Device Market report?

Ans: The Applications covered in the Autoimmune Disorder Drug Delivery Device Market report are In-house Manufacturing, Outsourced Manufacturing

What are the Type segmentation covered in the Autoimmune Disorder Drug Delivery Device Market report?

Ans: The Types covered in the Autoimmune Disorder Drug Delivery Device Market report are Pen Injectors, Auto-Injectors, Prefilled Syringes, Vials

Recommended Reports

Drug Delivery Devices

Drug Delivery Technologies

Autoimmune & Disorder Therapeutics

1 Autoimmune Disorder Drug Delivery Device Market Overview
1.1 Product Definition
1.2 Autoimmune Disorder Drug Delivery Device by Type
1.2.1 Global Autoimmune Disorder Drug Delivery Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pen Injectors
1.2.3 Auto-Injectors
1.2.4 Prefilled Syringes
1.2.5 Vials
1.3 Autoimmune Disorder Drug Delivery Device by Application
1.3.1 Global Autoimmune Disorder Drug Delivery Device Market Value by Application (2024 VS 2031)
1.3.2 In-house Manufacturing
1.3.3 Outsourced Manufacturing
1.4 Global Autoimmune Disorder Drug Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Autoimmune Disorder Drug Delivery Device Revenue 2020-2031
1.4.2 Global Autoimmune Disorder Drug Delivery Device Sales 2020-2031
1.4.3 Global Autoimmune Disorder Drug Delivery Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Autoimmune Disorder Drug Delivery Device Market Competition by Manufacturers
2.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Autoimmune Disorder Drug Delivery Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Autoimmune Disorder Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Product Type & Application
2.7 Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Date of Enter into This Industry
2.8 Global Autoimmune Disorder Drug Delivery Device Market Competitive Situation and Trends
2.8.1 Global Autoimmune Disorder Drug Delivery Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Autoimmune Disorder Drug Delivery Device Players Market Share by Revenue
2.8.3 Global Autoimmune Disorder Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Autoimmune Disorder Drug Delivery Device Market Scenario by Region
3.1 Global Autoimmune Disorder Drug Delivery Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Autoimmune Disorder Drug Delivery Device Sales by Region: 2020-2031
3.2.1 Global Autoimmune Disorder Drug Delivery Device Sales by Region: 2020-2025
3.2.2 Global Autoimmune Disorder Drug Delivery Device Sales by Region: 2026-2031
3.3 Global Autoimmune Disorder Drug Delivery Device Revenue by Region: 2020-2031
3.3.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Region: 2020-2025
3.3.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Region: 2026-2031
3.4 North America Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country
3.4.1 North America Autoimmune Disorder Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Autoimmune Disorder Drug Delivery Device Sales by Country (2020-2031)
3.4.3 North America Autoimmune Disorder Drug Delivery Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country
3.5.1 Europe Autoimmune Disorder Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2020-2031)
3.5.3 Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Region
3.6.1 Asia Pacific Autoimmune Disorder Drug Delivery Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Autoimmune Disorder Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Autoimmune Disorder Drug Delivery Device Sales by Country (2020-2031)
3.7.3 Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Autoimmune Disorder Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autoimmune Disorder Drug Delivery Device Sales by Type (2020-2031)
4.1.1 Global Autoimmune Disorder Drug Delivery Device Sales by Type (2020-2025)
4.1.2 Global Autoimmune Disorder Drug Delivery Device Sales by Type (2026-2031)
4.1.3 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2020-2031)
4.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2020-2031)
4.2.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2020-2025)
4.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2026-2031)
4.2.3 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2020-2031)
4.3 Global Autoimmune Disorder Drug Delivery Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Autoimmune Disorder Drug Delivery Device Sales by Application (2020-2031)
5.1.1 Global Autoimmune Disorder Drug Delivery Device Sales by Application (2020-2025)
5.1.2 Global Autoimmune Disorder Drug Delivery Device Sales by Application (2026-2031)
5.1.3 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2020-2031)
5.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Application (2020-2031)
5.2.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Application (2020-2025)
5.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Application (2026-2031)
5.2.3 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2020-2031)
5.3 Global Autoimmune Disorder Drug Delivery Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie Inc.
6.1.1 AbbVie Inc. Company Information
6.1.2 AbbVie Inc. Description and Business Overview
6.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Portfolio
6.1.5 AbbVie Inc. Recent Developments/Updates
6.2 Amgen Inc.
6.2.1 Amgen Inc. Company Information
6.2.2 Amgen Inc. Description and Business Overview
6.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Portfolio
6.2.5 Amgen Inc. Recent Developments/Updates
6.3 F. Hoffmann- La Roche Ltd.
6.3.1 F. Hoffmann- La Roche Ltd. Company Information
6.3.2 F. Hoffmann- La Roche Ltd. Description and Business Overview
6.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Portfolio
6.3.5 F. Hoffmann- La Roche Ltd. Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Company Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis AG Autoimmune Disorder Drug Delivery Device Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 GlaxoSmithKline Plc
6.5.1 GlaxoSmithKline Plc Company Information
6.5.2 GlaxoSmithKline Plc Description and Business Overview
6.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Portfolio
6.5.5 GlaxoSmithKline Plc Recent Developments/Updates
6.6 Biogen Inc.
6.6.1 Biogen Inc. Company Information
6.6.2 Biogen Inc. Description and Business Overview
6.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Portfolio
6.6.5 Biogen Inc. Recent Developments/Updates
6.7 Merck KGaA
6.7.1 Merck KGaA Company Information
6.7.2 Merck KGaA Description and Business Overview
6.7.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck KGaA Autoimmune Disorder Drug Delivery Device Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Bayer AG
6.8.1 Bayer AG Company Information
6.8.2 Bayer AG Description and Business Overview
6.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bayer AG Autoimmune Disorder Drug Delivery Device Product Portfolio
6.8.5 Bayer AG Recent Developments/Updates
6.9 Johnson & Johnson Services Inc.
6.9.1 Johnson & Johnson Services Inc. Company Information
6.9.2 Johnson & Johnson Services Inc. Description and Business Overview
6.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Portfolio
6.9.5 Johnson & Johnson Services Inc. Recent Developments/Updates
6.10 Teva Pharmaceutical Industries Ltd.
6.10.1 Teva Pharmaceutical Industries Ltd. Company Information
6.10.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Portfolio
6.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.11 Eli Lily and Company
6.11.1 Eli Lily and Company Company Information
6.11.2 Eli Lily and Company Description and Business Overview
6.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Portfolio
6.11.5 Eli Lily and Company Recent Developments/Updates
6.12 Sanofi S.A.
6.12.1 Sanofi S.A. Company Information
6.12.2 Sanofi S.A. Description and Business Overview
6.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Portfolio
6.12.5 Sanofi S.A. Recent Developments/Updates
6.13 Takeda Pharmaceutical Company Limited
6.13.1 Takeda Pharmaceutical Company Limited Company Information
6.13.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Portfolio
6.13.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autoimmune Disorder Drug Delivery Device Industry Chain Analysis
7.2 Autoimmune Disorder Drug Delivery Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autoimmune Disorder Drug Delivery Device Production Mode & Process Analysis
7.4 Autoimmune Disorder Drug Delivery Device Sales and Marketing
7.4.1 Autoimmune Disorder Drug Delivery Device Sales Channels
7.4.2 Autoimmune Disorder Drug Delivery Device Distributors
7.5 Autoimmune Disorder Drug Delivery Device Customer Analysis
8 Autoimmune Disorder Drug Delivery Device Market Dynamics
8.1 Autoimmune Disorder Drug Delivery Device Industry Trends
8.2 Autoimmune Disorder Drug Delivery Device Market Drivers
8.3 Autoimmune Disorder Drug Delivery Device Market Challenges
8.4 Autoimmune Disorder Drug Delivery Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Amgen Inc
F Hoffmann La Roche Ltd
Novartis
GlaxoSmithKline PLC
Biogen
Merck KGaA
Bayer
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd
Eli Lily And Company
Sanofi
Takeda Pharmaceutical Company Limited
List of Tables
 Table 1. Global Autoimmune Disorder Drug Delivery Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Autoimmune Disorder Drug Delivery Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Autoimmune Disorder Drug Delivery Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Autoimmune Disorder Drug Delivery Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Autoimmune Disorder Drug Delivery Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Autoimmune Disorder Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Product Type & Application
 Table 12. Global Key Manufacturers of Autoimmune Disorder Drug Delivery Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Autoimmune Disorder Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorder Drug Delivery Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Autoimmune Disorder Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Autoimmune Disorder Drug Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2020-2025)
 Table 19. Global Autoimmune Disorder Drug Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2026-2031)
 Table 21. Global Autoimmune Disorder Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Autoimmune Disorder Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Autoimmune Disorder Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Autoimmune Disorder Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Autoimmune Disorder Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Autoimmune Disorder Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Autoimmune Disorder Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Autoimmune Disorder Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Autoimmune Disorder Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2020-2025)
 Table 53. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2026-2031)
 Table 54. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Autoimmune Disorder Drug Delivery Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2020-2025)
 Table 63. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2026-2031)
 Table 64. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Autoimmune Disorder Drug Delivery Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie Inc. Company Information
 Table 71. AbbVie Inc. Description and Business Overview
 Table 72. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product
 Table 74. AbbVie Inc. Recent Developments/Updates
 Table 75. Amgen Inc. Company Information
 Table 76. Amgen Inc. Description and Business Overview
 Table 77. Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Amgen Inc. Autoimmune Disorder Drug Delivery Device Product
 Table 79. Amgen Inc. Recent Developments/Updates
 Table 80. F. Hoffmann- La Roche Ltd. Company Information
 Table 81. F. Hoffmann- La Roche Ltd. Description and Business Overview
 Table 82. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product
 Table 84. F. Hoffmann- La Roche Ltd. Recent Developments/Updates
 Table 85. Novartis AG Company Information
 Table 86. Novartis AG Description and Business Overview
 Table 87. Novartis AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis AG Autoimmune Disorder Drug Delivery Device Product
 Table 89. Novartis AG Recent Developments/Updates
 Table 90. GlaxoSmithKline Plc Company Information
 Table 91. GlaxoSmithKline Plc Description and Business Overview
 Table 92. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product
 Table 94. GlaxoSmithKline Plc Recent Developments/Updates
 Table 95. Biogen Inc. Company Information
 Table 96. Biogen Inc. Description and Business Overview
 Table 97. Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Biogen Inc. Autoimmune Disorder Drug Delivery Device Product
 Table 99. Biogen Inc. Recent Developments/Updates
 Table 100. Merck KGaA Company Information
 Table 101. Merck KGaA Description and Business Overview
 Table 102. Merck KGaA Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck KGaA Autoimmune Disorder Drug Delivery Device Product
 Table 104. Merck KGaA Recent Developments/Updates
 Table 105. Bayer AG Company Information
 Table 106. Bayer AG Description and Business Overview
 Table 107. Bayer AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bayer AG Autoimmune Disorder Drug Delivery Device Product
 Table 109. Bayer AG Recent Developments/Updates
 Table 110. Johnson & Johnson Services Inc. Company Information
 Table 111. Johnson & Johnson Services Inc. Description and Business Overview
 Table 112. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product
 Table 114. Johnson & Johnson Services Inc. Recent Developments/Updates
 Table 115. Teva Pharmaceutical Industries Ltd. Company Information
 Table 116. Teva Pharmaceutical Industries Ltd. Description and Business Overview
 Table 117. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product
 Table 119. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 120. Eli Lily and Company Company Information
 Table 121. Eli Lily and Company Description and Business Overview
 Table 122. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product
 Table 124. Eli Lily and Company Recent Developments/Updates
 Table 125. Sanofi S.A. Company Information
 Table 126. Sanofi S.A. Description and Business Overview
 Table 127. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product
 Table 129. Sanofi S.A. Recent Developments/Updates
 Table 130. Takeda Pharmaceutical Company Limited Company Information
 Table 131. Takeda Pharmaceutical Company Limited Description and Business Overview
 Table 132. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product
 Table 134. Takeda Pharmaceutical Company Limited Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Autoimmune Disorder Drug Delivery Device Distributors List
 Table 138. Autoimmune Disorder Drug Delivery Device Customers List
 Table 139. Autoimmune Disorder Drug Delivery Device Market Trends
 Table 140. Autoimmune Disorder Drug Delivery Device Market Drivers
 Table 141. Autoimmune Disorder Drug Delivery Device Market Challenges
 Table 142. Autoimmune Disorder Drug Delivery Device Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Autoimmune Disorder Drug Delivery Device
 Figure 2. Global Autoimmune Disorder Drug Delivery Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Autoimmune Disorder Drug Delivery Device Market Share by Type: 2024 & 2031
 Figure 4. Pen Injectors Product Picture
 Figure 5. Auto-Injectors Product Picture
 Figure 6. Prefilled Syringes Product Picture
 Figure 7. Vials Product Picture
 Figure 8. Global Autoimmune Disorder Drug Delivery Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Autoimmune Disorder Drug Delivery Device Market Share by Application: 2024 & 2031
 Figure 10. In-house Manufacturing
 Figure 11. Outsourced Manufacturing
 Figure 12. Global Autoimmune Disorder Drug Delivery Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Autoimmune Disorder Drug Delivery Device Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Autoimmune Disorder Drug Delivery Device Sales (2020-2031) & (K Units)
 Figure 15. Global Autoimmune Disorder Drug Delivery Device Average Price (US$/Unit) & (2020-2031)
 Figure 16. Autoimmune Disorder Drug Delivery Device Report Years Considered
 Figure 17. Autoimmune Disorder Drug Delivery Device Sales Share by Manufacturers in 2024
 Figure 18. Global Autoimmune Disorder Drug Delivery Device Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Autoimmune Disorder Drug Delivery Device Players: Market Share by Revenue in Autoimmune Disorder Drug Delivery Device in 2024
 Figure 20. Autoimmune Disorder Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Autoimmune Disorder Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 23. North America Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 24. United States Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 27. Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2020-2031)
 Figure 35. China Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Autoimmune Disorder Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Autoimmune Disorder Drug Delivery Device by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Autoimmune Disorder Drug Delivery Device by Type (2020-2031)
 Figure 57. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Autoimmune Disorder Drug Delivery Device by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Autoimmune Disorder Drug Delivery Device by Application (2020-2031)
 Figure 60. Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit) by Application (2020-2031)
 Figure 61. Autoimmune Disorder Drug Delivery Device Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Autoimmune Disorder Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Disease Therapeutics Market Research Report 2024
Systemic Autoimmune Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Localized Autoimmune Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Diseases Treatment Market Research Report 2024
Clinical Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Needle Free Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Disease Testing Market Research Report 2024
Global Self Injection Medical Device Market Research Report 2024
Electronic Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Implantable Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Unit Dose Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Obesity Treatment Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Smart Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bleeding Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Novel Cardiovascular Drug Delivery Devices Market Research Report 2024
Infusion Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alternative Drug Delivery Systems Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions